Hyundai Pharm (004310) — Cash Flow Quality Index
Hyundai Pharm (004310) has a Cash Flow Quality Index of 0.45x as of February 2026. Operating cash flow of ₩188.28 Million is below net income of ₩420.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 004310 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hyundai Pharm Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for Hyundai Pharm across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Hyundai Pharm's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hyundai Pharm (2010–2025)
Year-by-year earnings quality comparison for Hyundai Pharm. For live market cap and the full company financial profile, see Hyundai Pharm market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.05x | ₩-123.29 Million | ₩2.52 Billion | ▲ +93.4% |
| 2023 | -0.74x | ₩-4.55 Billion | ₩6.12 Billion | ▼ -115.0% |
| 2020 | 4.94x | ₩10.80 Billion | ₩2.19 Billion | ▼ -17.8% |
| 2019 | 6.01x | ₩6.96 Billion | ₩1.16 Billion | ▲ +97.0% |
| 2018 | 3.05x | ₩2.83 Billion | ₩928.94 Million | ▲ +324.6% |
| 2017 | -1.36x | ₩-1.98 Billion | ₩1.46 Billion | ▲ +37.6% |
| 2016 | -2.18x | ₩-2.75 Billion | ₩1.26 Billion | ▼ -138.8% |
| 2013 | 5.62x | ₩7.95 Billion | ₩1.41 Billion | ▼ -53.4% |
| 2011 | 12.05x | ₩6.27 Billion | ₩520.10 Million | ▲ +1235.5% |
| 2010 | 0.90x | ₩2.68 Billion | ₩2.97 Billion | — |